February is International Prenatal Infection Awareness Month, a vital time to highlight the importance of hepatitis B screening during pregnancy. All pregnant women should be tested for hepatitis B to ensure their baby is protected at birth.

If a mother has hepatitis B, doctors can take the necessary steps to prevent transmission, including administering the hepatitis B birth dose vaccine and hepatitis B immune globulin (HBIG) immediately after delivery. These simple but crucial measures can safeguard a newborn from lifelong infection.

Talk to your doctor about hepatitis B testing during pregnancy—early detection saves lives! Please visit our website to learn more about pregnancy and hepatitis B.

Liver cancer is on the rise, but prevention is possible. Chronic hepatitis B infection is a leading risk factor, making hepatitis B vaccination a critical tool in the fight against liver cancer.

The hepatitis B vaccine—the first-ever "anti-cancer" vaccine—prevents chronic infections and has dramatically reduced liver cancer cases worldwide. In the U.S., it is recommended for all infants, children, and adults up to age 59, with high-risk individuals over 60 also encouraged to get vaccinated.

Join us in taking a stand against liver cancer and hepatitis B—prevention starts with awareness and action! You can read more here.

Clinical Care Options, in partnership with Hepatitis B Foundation and American Liver Foundation, have developed a new online tool “Hep B Consult: US, European, and Asian-Pacific Guideline Recommendations on Whether and How to Treat HBV and HDV.” This Interactive Decision Support Tool offers guideline-based patient-specific HBV and HDV management recommendations.

You can begin the activity by accessing the tool here.

Don't miss out on our upcoming webinars – these sessions promise to be incredibly informative!

The Coalition Against Hepatitis for People of African Origin (CHIPO) interviewed Assita Belemkoabga with the Hepatitis Outreach Network (HONE) at the Icahn School of Medicine at Mount Sinai Hospital in NYC. Hear her insights on challenges, successes, and the future of hepatitis B advocacy. Read the blog here.

The Coalition Against Hepatitis for People of African Origin is a community coalition co-founded and led by the Hepatitis B Foundation. CHIPO serves as a forum to improve hepatitis B awareness, testing, vaccination and treatment among highly affected African communities. Learn more here.

New #BtheVoice storytellers from Uganda

share their journeys with hepatitis B

We are thrilled to introduce five new #BtheVoice storytellers from Uganda, in partnership with the National Organization for People Living with Hepatitis B. These inspiring individuals are breaking the silence around hepatitis B by sharing their experiences of diagnosis, stigma and resilience.

Geoffrey discovered he was born with hepatitis B during a medical checkup and, despite facing stigma and ineffective treatments, now manages his condition with proper guidance. Joseph struggled after being disqualified from a job due to his diagnosis but found hope through education and support. Naume was diagnosed during pregnancy and, with support from her doctor and husband, has learned that hepatitis B is manageable with the right care. Philip turned his shock into action by founding an organization to educate communities about hepatitis B. Susan initially took her diagnosis lightly but later realized the importance of medical care and encourages others to stay strong. 

New B Informed Training Hub module:

Diagnosis and treatment of hepatitis B and D

We’re happy to announce the launch of our Diagnosis and Treatment of Hepatitis B/D training module! This educational resource is designed to provide in-depth knowledge for health care professionals, hepatitis B and delta patients and advocates.

Access the training module here and take the next step in advancing your knowledge and advocacy!

The Hepatitis B Foundation has launched a hepatitis delta survey, in order to better understand the experiences of people who living with hepatitis delta, from testing to diagnosis to management. We hope this will lead to a better understanding of the virus and help us advocate for better testing and treatment.

The survey should take less than 10 minutes to complete. There's an option to participate in a short interview to further discuss your experiences. The survey, which has been translated into 14 languages, can be found here.

New clinical trial opportunity available for people

living with chronic hepatitis B virus infection 

Check out this new clinical trial opportunity! GSK is launching a phase 2b study called B-United, which will test a study drug called daplusiran/tomligisiran (DAP/TOM) followed by another study drug called bepirovirsen as a potential new treatment for chronic hepatitis B virus infection.   

You may be eligible to participate in the B-United study if you: 

• Are at least 18 years old (the minimum age may be higher in some countries);  
• Have had diagnosed chronic hepatitis B infection documented for at least six months;  
• Have been on stable nucleoside/nucleotide analogue (NA) treatment (sometimes referred to as antivirals, such as tenofovir or entecavir) for the past 6 months, without any changes for the past 3 months.

If eligible, you will continue NA treatment and receive an investigational therapy that consists of: 

1. daplusiran/tomligisiran OR placebo for 24 weeks followed by 
2. bepirovirsen for 24 weeks 



Following study treatment with daplusiran/tomligisiran (or placebo) and bepirovirsen, you will continue your NA treatment for 24 more weeks. The study doctor will then determine if you can stop your NA treatment and, if so, you will be off-NA treatment for up to 28 weeks while closely monitored by the study doctor. 

The study is being run in many countries around the world.

To find out more information and see if you might be eligible,

please visit www.BUnitedStudy.com. 

New resource for providers: Adult HBV screening information

The Hepatitis B Foundation is excited to announce a new resource designed specifically for medical providers: Adult Hepatitis B Screening Information for Providers. This comprehensive fact sheet offers essential details to support health care professionals in screening, testing and vaccinating adults for hepatitis B.

This resource equips providers with the tools needed to ensure accurate diagnosis, effective patient management and lifelong protection against hepatitis B.

For more information and to access the fact sheet, please click here. Together, let’s enhance care for patients and advance hepatitis B prevention and treatment.

New online education course on Simplified HBV Screening

and Treatment: Register now to earn CME credits

There is an exciting new educational opportunity for health care providers! The two-session webinar-based course will discuss strategies for implementing HBV/HDV screening, simplified HBV treatment and increasing adherence and engagement in care, with a focus on Asian American and African immigrant communities. The sessions are Jan. 16 and Feb. 12. The course is hosted by Clinical Care Options (CCO) in partnership with the Asian Health Foundation and Hepatitis B Foundation. Register now!

Existing knowledge, myths, and perceptions about hepatitis B and liver cancer within highly impacted immigrant communities

Journal of Virus Eradication

Dec. 17, 2024



2024;10(2):100379

Click here to access the article.

Chen C, Borondy-Jenkins F, Zovich B, Block SJ, Moraras K, Chan A, Cohen C.

Conclusion: "To reduce hepatitis B and liver cancer health disparities within heavily burdened groups, health education needs to be community-informed, culturally sensitive, and actionable. Study results can guide the development of culturally and linguistically appropriate education programs that focus on the link between hepatitis B and liver cancer and the need for vaccination and routine screening, and that are responsive to the knowledge gaps and misperceptions of diverse communities. The results also provide valuable insights for healthcare providers to improve the knowledge gaps of the diverse patient populations that they serve."

 Seeking youth & adolescent perspectives on hepatitis B

The Hepatitis B Foundation wants to learn about the experiences of young people living with hepatitis B to improve care and support. We are asking all

youth living with hep B to participate in a brief survey. Their insights will help inform clinicians and health care professionals about the unique needs of youth and adolescents. Sign up here.

Questions? Reach out to Catherine.Freeland@hepb.org